HAEMONINE

This brand name is authorized in Austria, Tunisia, Turkey, UK.

Active ingredients

The drug HAEMONINE contains one active pharmaceutical ingredient (API):

1	Human plasma coagulation factor IX concentrate UNII 6U90Y1795T - COAGULATION FACTOR IX HUMAN
	Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X.
	Read more about Coagulation factor IX

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HAEMONINE Powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD04	Coagulation factor IX	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	327515, 327517
TN	Direction de la Pharmacie et du Médicament	8153081H, 8153082H
TR	İlaç ve Tıbbi Cihaz Kurumu	8682109319874, 8682109319881